Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

《药物靶向杂志》发表有关分子和大分子药物的药物输送和靶向的各个方面的论文和评论，包括这些药物体外和/或体内应用的载体系统（无论是胶体、蛋白质还是聚合物）的设计和特性。

论文不仅限于通过载体输送的药物，还包括旨在靶向特定细胞或细胞外分子的分子和大分子药物的研究。因此，该杂志发表了关于治疗性肽/蛋白质和核酸（包括基因/质粒 DNA、基因沉默核酸（例如小干扰 (si)RNA、反义寡核苷酸、核酶、DNA 酶）以及适体、单核苷酸和单克隆抗体及其结合物的活性、输送和靶向性的结果。靶向技术的诊断应用以及诊断和成像剂的靶向输送也属于该杂志的范围。此外，我们还寻求有关自我调节系统、对环境和外部刺激有反应的系统以及可以产生程序化、脉冲和其他复杂传递模式的系统的文章。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-药学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.3，平均审稿速度为 约2月 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。